References
- United Nations. World Contraceptive Use 2007. New York (NY): United Nations Publications; 2007.
- Bayer HealthCare Pharmaceuticals. Mirena Physician Prescribing Information; 2008.
- Rönnerdag M, Odlind V. Health effects of long-term use of the intrauterine levonorgestrel-releasing system. Acta Obstet Gynecol Scand. 1999;78(8):716–721.
- Arnes M, Hvingel B, Orbo A. Levonorgestrel-impregnated intrauterine device reduces occurrence of hyperplastic polyps: a population-based follow-up cohort study. Anticancer Res. 2014;34(5):2319–2324.
- Wan YL, Holland C. The efficacy of levonorgestrel intrauterine systems for endometrial protection: a systematic review. Climacteric. 2011;14(6):622–632.
- Senol T, Kahramanoglu I, Dogan Y, et al. Levonorgestrel-releasing intrauterine device use as an alternative to surgical therapy for uterine leiomyoma. Clin Exp Obstet Gynecol. 2015;42(2):224–227.
- Wamsteker K, Emanuel MH, De Kruif JH. Transcervicalhysteroscopic resection of submucous fibroids for abnormal uterine bleeding: results regarding the degrese of intramural extension. ObstetGynecol. 1993;82:736–740.
- Munro MG, Critchley HOD, Fraser IS. The FIGO classification of causes of abnormal uterine bleeding: Malcolm G. Munro, Hilary O.D. Crithcley, Ian S. Fraser, for the FIGO Working Group on Menstrual Disorders. Int J Gynaecol Obstet. 2011;113(1):1–2.
- Fraser IS, Critchley HO, Munro MG. Abnormal uterine bleeding: getting our terminology straight. CurrOpinObstetGynecol. 2007;19:591–595.
- Laganà AS, Vergara D, Favilli A, et al. Epigenetic and genetic landscape of uterine leiomyomas: a current view over a common gynecological disease. Arch Gynecol Obstet. 2017;296(5):855–867.
- Indraccolo U, Di Iorio R, Matteo M, et al. The pathogenesis of endometrial polyps: a systematic semi-quantitative review. Eur J GynaecolOncol. 2013;34:5–22.
- Kosei N, Zakharenko N, Herman D. Endometrial polyps in women of reproductive age: clinical and pathogenetic variations. Georgian Med News. 2017;273:16–22.
- Stewart EA. Uterine fibroids. Lancet. 2001;357(9252):293–298.
- Vitagliano A, Noventa M, Di Spiezio Sardo A, et al. Uterine fibroid size modifications during pregnancy and puerperium: evidence from the first systematic review of literature. Arch Gynecol Obstet. 2018;297(4):823–835.
- Laganà AS, Giacobbe A, Triolo O, et al. Dienogest as preoperative treatment of submucous myomas for hysteroscopic surgery: a prospective, randomized study. Gynecol Endocrinol. 2016;32(5):408–411.
- Laganà AS, Vitale SG, Muscia V, et al. Endometrial preparation with Dienogest before hysteroscopic surgery: a systematic review. Arch Gynecol Obstet. 2017;295(3):661–667.
- Bettocchi S, Nappi L, Ceci O, et al. Office hysteroscopy. Obstet Gynecol Clin North Am. 2004;31(3):641–654.